Home LiteratureArticle Details
PMID: 8668211 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Alpha interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible G0-like arrest.

Molecular and cellular biology ·Vol. 16 ·No. 7 ·1996-07-00 ·Pages 3934-44

Tiefenbrun N, Melamed D, Levy N, Resnitzky D, Hoffman I, Reed SI, Kimchi A

Abstract

Alpha interferon is a potent growth inhibitor of Daudi Burkitt's lymphoma cells. We show here that alpha-interferon signaling interacted simultaneously with several components of the basic cell cycle machinery, causing cells to enter into a state that had many features characteristic of the G0 state. Within a few hours after alpha-interferon treatment, cyclin D3 mRNA and protein levels dropped to undetectable levels and, in parallel, the activities of cyclin A- and cyclin E-associated kinases were significantly reduced. The latter resulted from the rapid alpha-interferon-mediated elimination of cdc25A, a phosphatase that is required for antagonism of negative tyrosine phosphorylation of cdk2 in cyclin-cdk complexes. This regulation represents a novel mechanism through which an external inhibitory cytokine interacts with the cell cycle machinery. At later time points after alpha-interferon treatment, the levels of the 55-kDa slowly migrating hyperphosphorylated form of cyclin E and of cyclin A were also reduced. The antiproliferative effects were reversible, and cultures from which alpha interferon was removed reentered S phase after a lag that typically corresponded to approximately two doubling times. During this lag period, the expression of cyclin D3 and cyclin A, as well as of the cdc25A phosphatase, continued to be switched off, in spite of the removal of alpha interferon from the cell surface. In contrast, c-myc, which represents another downstream target gene that is subjected to negative regulation by alpha interferon, was relieved from suppression much earlier, concomitant with the decay in early signaling of the cytokine. The delayed pattern of cyclin reexpression provides evidence that alpha-interferon signaling imposes a G0-like state on this system.

MeSH Terms
Burkitt Lymphoma Cell Cycle/drug effects Cell Cycle Proteins/biosynthesis,metabolism Cell Division/drug effects Cell Line Cyclin D3 Cyclin-Dependent Kinases/metabolism Cyclins/biosynthesis,isolation & purification GTP-Binding Proteins/biosynthesis Gene Expression Regulation, Neoplastic/drug effects Humans Interferon-alpha/pharmacology Kinetics Phosphoprotein Phosphatases/biosynthesis,metabolism Resting Phase, Cell Cycle Suppression, Genetic Tetradecanoylphorbol Acetate/pharmacology Time Factors Tumor Cells, Cultured cdc25 Phosphatases
Chemicals
CCND3 protein, human Cell Cycle Proteins Cyclin D3 Cyclins Interferon-alpha Cyclin-Dependent Kinases Phosphoprotein Phosphatases cdc25 Phosphatases GTP-Binding Proteins Tetradecanoylphorbol Acetate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Tiefenbrun N
Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot, Israel.
Melamed D
Levy N
Resnitzky D
Hoffman I
Reed S I
Kimchi A
References (40)
40 references, click to expand
  1. An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.
    Cell. 1984 Apr;36(4):897-906 PMID: 6231105
  2. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
    Genes Dev. 1995 Aug 1;9(15):1831-45 PMID: 7649471
  3. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.
    Mol Cell Biol. 1985 Dec;5(12):3610-6 PMID: 3915782
  4. Tumor necrosis factor reduces c-myc expression and cooperates with interferon-gamma in HeLa cells.
    Science. 1986 Dec 12;234(4782):1419-21 PMID: 3097823
  5. Purification of the major protein-tyrosine-phosphatases of human placenta.
    J Biol Chem. 1988 May 15;263(14):6722-30 PMID: 2834386
  6. Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis.
    Mol Cell Biol. 1988 Jul;8(7):2828-36 PMID: 3043196
  7. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes.
    Cell. 1989 Aug 25;58(4):729-39 PMID: 2475256
  8. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.
    Cell. 1989 Sep 22;58(6):1085-95 PMID: 2673542
  9. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.
    Cell. 1990 Jun 1;61(5):777-85 PMID: 2140528
  10. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation.
    Cell. 1990 Jul 13;62(1):175-85 PMID: 2163767
  11. Transforming growth factor beta 1 inhibition of p34cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest.
    Mol Cell Biol. 1991 Mar;11(3):1185-94 PMID: 1996085
  12. Deregulated c-myc expression abrogates the interferon- and interleukin 6-mediated G0/G1 cell cycle arrest but not other inhibitory responses in M1 myeloblastic cells.
    Cell Growth Differ. 1991 Jan;2(1):33-41 PMID: 1706617
  13. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle.
    Cell. 1991 May 17;65(4):701-13 PMID: 1827757
  14. The involvement of protein kinase C in mediating growth suppressive signals of interferons in hematopoietic cells.
    Oncogene. 1991 Jun;6(6):1001-7 PMID: 1712443
  15. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.
    Nature. 1991 Jul 25;352(6333):345-7 PMID: 1852210
  16. p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast.
    EMBO J. 1991 Dec;10(13):4301-9 PMID: 1756737
  17. Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells.
    Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):402-6 PMID: 1370354
  18. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1795-8 PMID: 1531876
  19. Cyclin A is required at two points in the human cell cycle.
    EMBO J. 1992 Mar;11(3):961-71 PMID: 1312467
  20. The retinoblastoma protein is partially phosphorylated during early G1 in cycling cells but not in G1 cells arrested with alpha-interferon.
    Oncogene. 1992 Apr;7(4):783-8 PMID: 1565475
  21. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
    EMBO J. 1992 Nov;11(11):3995-4005 PMID: 1396589
  22. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
    Genes Dev. 1992 Oct;6(10):1874-85 PMID: 1398067
  23. Association of human cyclin E with a periodic G1-S phase protein kinase.
    Science. 1992 Sep 25;257(5078):1958-61 PMID: 1329201
  24. Cytokine triggered molecular pathways that control cell cycle arrest.
    J Cell Biochem. 1992 Sep;50(1):1-9 PMID: 1385455
  25. The role of p34 kinases in the G1 to S-phase transition.
    Annu Rev Cell Biol. 1992;8:529-61 PMID: 1476805
  26. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
    Science. 1993 Apr 23;260(5107):536-9 PMID: 8475385
  27. The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
    Oncogene. 1993 Jun;8(6):1593-602 PMID: 8502482
  28. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
    Mol Cell Biol. 1993 Sep;13(9):5255-65 PMID: 7689148
  29. TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest.
    Cell. 1993 Sep 24;74(6):1009-20 PMID: 8402878
  30. Transforming growth factor beta effects on expression of G1 cyclins and cyclin-dependent protein kinases.
    Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10315-9 PMID: 7694291
  31. Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression.
    Mol Cell Biol. 1993 Dec;13(12):7942-52 PMID: 8247009
  32. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.
    Mol Cell Biol. 1994 Mar;14(3):1669-79 PMID: 8114703
  33. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.
    Cell. 1994 Mar 25;76(6):1013-23 PMID: 8137420
  34. Cdc25A is a novel phosphatase functioning early in the cell cycle.
    EMBO J. 1994 Apr 1;13(7):1549-56 PMID: 8156993
  35. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
    Cell. 1994 Jul 15;78(1):59-66 PMID: 8033212
  36. p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
    Nature. 1994 Sep 15;371(6494):257-61 PMID: 8078588
  37. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
    EMBO J. 1994 Sep 15;13(18):4302-10 PMID: 7523110
  38. Cdk inhibitors: on the threshold of checkpoints and development.
    Curr Opin Cell Biol. 1994 Dec;6(6):847-52 PMID: 7880532
  39. The retinoblastoma tumor suppressor protein.
    Curr Opin Genet Dev. 1995 Feb;5(1):79-83 PMID: 7749330
  40. Close link between reduction of c-myc expression by interferon and, G0/G1 arrest.
    Nature. 1985 Feb 14-20;313(6003):597-600 PMID: 3881681
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
1996-07-00
Pages
3934-44
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC231390
Subset
IM
Grants
NIGMS NIH HHS · GM46006 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com